Joseph J. Larosa - 03 Jan 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Issuer symbol
REGN
Transactions as of
03 Jan 2024
Net transactions value
-$8,756,524
Form type
4
Filing time
04 Jan 2024, 16:19:41 UTC
Previous filing
12 Dec 2023
Next filing
09 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $13,588,440 +34,000 +113% $399.66 64,036 03 Jan 2024 Direct
transaction REGN Common Stock Tax liability $22,344,964 -24,493 -38% $912.30 39,543 03 Jan 2024 Direct
holding REGN Common Stock 3,367 03 Jan 2024 2022 GRAT
holding REGN Common Stock 355 03 Jan 2024 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -34,000 -100% $0.000000* 0 03 Jan 2024 Common Stock 34,000 $399.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.